Screener
Neuronetics STIM Ratios & Valuation
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 49.1%-7.0pp | 48%-15.6pp | 48.5%-23.8pp | 50.4%-25.3pp | 56.2%-17.1pp | |
| Operating margin | -14.7%+19.7pp | -19.4%+23.9pp | -21.1%+25.1pp | -29.2%+8.7pp | -34.4%+5.3pp | |
| Net margin | -19.6%+24.3pp | -24.5%+29.8pp | -26.1%+32.2pp | -34.3%+15.8pp | -43.9%+1.1pp | |
| Returns | ||||||
| Return on equity | -135.3%+74.5pp | -152.4%+1.4pp | -155.7%-14.5pp | -242.3%-88.3pp | -209.7%-110pp | |
| Return on invested capital | -25.1%+31.1pp | -32.1%+23.1pp | -35.6%+18.0pp | -59.5%+9.8pp | -56.2%+16.2pp | |
| Efficiency | ||||||
| Asset turnover | 1.2×+0.2× | 1.1×+0.4× | 1.1×+0.5× | 1.2×+0.3× | 1×+0.2× | |
| Liquidity | ||||||
| Current ratio | 1.9×-0.1× | 1.7×-0.8× | 2×+0.2× | 2.2×-0.9× | 2×-0.6× | |
| Leverage | ||||||
| Debt-to-equity | 4.8×+1.9× | 6.4×+4.1× | 4×+1.1× | 3.3×-1.9× | 3×-0.3× | |
| Per Share | ||||||
| Book value per share | $0.24-40.5% | $0.19-67.0% | $0.34-61.1% | $0.41+31.1% | $0.41-36.4% | |
| Valuation | ||||||
| Market capitalization | $213.35M+11.6% | $100.45M-57.9% | $94.51M+5.5% | $180.52M+691% | $233M+339% | |
| Price / sales | 1.4×-0.3× | 0.7×-2.0× | 0.6×-0.6× | 1.4×+1.1× | 2.1×+1.4× | |
| Price / book | 11.8×+4.8× | 7.6×+0.8× | 4.2×+1.0× | 6.6×+4.2× | 8.6×+5.8× |
FAQ
- What are Neuronetics's profit margins?
- Neuronetics (STIM) runs a 49.1% gross margin and a -14.7% operating margin, with a -19.6% net margin.
- Where do Neuronetics's ratios come from?
- Every ratio is computed from Neuronetics's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
